Carlina Technologies Overview

  • Founded

  • 2010

Founded
  • Status

  • Out of Business

  • Employees

  • 3

Employees
  • Latest Deal Type

  • Out of Business

Carlina Technologies General Information

Description

Developer of nano medicines designed to relieve patients suffering from many diseases. The company's medicines utilize innovative non-denaturing drug delivery technologies for therapeutic proteins, peptides and other types of drugs, enabling patients to improve compliance and quality of life.

Contact Information

Website
www.carlinatech.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • 22 rue Roger Amsler
  • 49100 Angers
  • France
+33 02 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carlina Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 06-May-2021 0000 Completed Out of Business
5. Equity Crowdfunding 04-Apr-2016 00000 0000 Completed Generating Revenue
4. Accelerator/Incubator 01-Mar-2015 000.00 Completed Generating Revenue
3. Early Stage VC 03-Nov-2014 000.00 000.00 Completed Startup
2. Early Stage VC 06-Mar-2013 $432K Completed Startup
1. Early Stage VC 10-Dec-2012 $432K $432K Completed Startup
To view Carlina Technologies’s complete valuation and funding history, request access »

Carlina Technologies Patents

  • 3

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Carlina Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180009841-A1 Method for preparing nanoprecipitates of low molecular weight peptide or protein Inactive 26-Aug-2014 00000000 0
EP-3217961-A1 Method for preparing nanoprecipitates of low molecular weight peptide or protein Inactive 26-Aug-2014 00000000
EP-2990033-A1 Process of nanoprecipitation of proteins and peptides with low molecular weight Inactive 26-Aug-2014 A61K9/14 0

Carlina Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial